> Skip repeated content
Dr. Bass headshot

Anne R. Bass, MD

Phone Icon Image
Dr. Bass headshot

Anne R. Bass, MD

Phone Icon Image

Dr. Bass is an Attending Physician in the Division of Rheumatology at Hospital for Special Surgery and a Professor of Clinical Medicine at Weill Cornell Medicine. She specializes in the treatment of patients with autoimmune side effects of cancer immunotherapy, and also sees patients with rheumatoid arthritis, vasculitis, systemic lupus erythematosus, and autoimmune eye and ear disease. Dr. Bass co-directs the HSS Checkpoint inhibitor associated arthritis registry and is doing translational research to better understand this condition.

Patient Stories


Attending Physician, Hospital for Special Surgery
Professor of Clinical Medicine, Weill Cornell Medical College


Specialized Centers

Special Expertise

Cancer Immunotherapy
Rheumatoid Arthritis
Psoriatic Arthritis
Venous Thromboembolism
Inflammatory Eye Disease


Castle Connolly Top Regional Doctor, 2014-2020
New York Magazine Top Doctors, 2014-2021
Castle Connolly Top Doctors in New York Metro Area, 2015-2021




Insurance Information

Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may have coverage subject to the availability of 'out-of-network' benefits.

Patient ratings for Dr. Bass

Industry Relationships

One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.

As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.

As of December 22, 2020, Dr. Bass reported no relationships with healthcare industry.

By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.

Dr. Bass in the News


MD, Columbia College of Physicians and Surgeons, New York


Columbia Presbyterian Medical Center


New York University Medical Center


Internal Medicine, 1988
Rheumatology, 1992, 2002, 2012

State Licensure

Patient Education by Dr. Bass on HSS.edu

Blog Posts by Dr. Bass

Selected Books by Dr. Bass

Bass AR. “Venous Thromboembolism and Orthopedic Surgery” in Perioperative Care of the Orthopedic Patient. MacKenzie CR, Cornell CN, Memtsoudis SG eds. Springer 2019

Bass AR, Rogatsky I. Immunomodulatory drugs. Cecil’s Textbook of Medicine. 26th edition. Goldman, Schafer ed. Elsevier 2019

Selected Publications


Goodman SM, Mandl LA, Parks ML, Zhang M, McHugh KR, Lee Y-Y, Nguyen JT, Russell LA, Bogardus MH, Figgie MP, Bass AR. Disparities in total Knee Arthroplasty Outcomes: Census Tract Data Demonstrates Interactions between Race and Poverty. Clinical orthopaedics and related research. 2016; 474(9):1986-95. PMID: 27278675, PMCID: PMC4965380

Bass, AR, McHugh K, Fields K, Goto R, Goodman S. Higher Knee Arthroplasty Revision Rates among U.S. Blacks: a Systematic Literature Review and Meta-Analysis J Bone Joint Surg (Am) 2016; 98(24):2103-2108. PMID: 28002374.

Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodríguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple BD, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial. JAMA. 2017 Sep 26;318(12):1115-112

Bolster MB, Bass A, Monrad S, Ditmyer M, Batttafarano D.  2015 ACR/ARHP Workforce Study in the U.S.: The Role of Graduate Medical Education (GME) in Adult Rheumatology. Arthritis Rheum 2018 PMID 29399986

Bass AR, Mehta B, Szymonifka MA, Lyman S, Lai E, Parks M, Figgie M, Mandl L, Goodman S. Racial Disparities in Total Knee Replacement Failure Are Not Explained by Poverty. AC&R. EPub 2019. PMID 31309739

Gage BF, Bass AR, Lin H, Woller S, Stevens S, Al-Hammadi N, Li J, Rodriguez T, Miller JP, McMilin G, Pendleton R, Jaffer A, King C, DeVore B, Porche-Sorbet R, Napoli L, Merritt K, Thompson A, Hyun G, Anderson J, Hollomon W, Barrack R, Nunleys R, Moskowitz G, Davila-Roman V, Eby C. Genetics Informatics Trial (GIFT) of Warfarin to Prevent Deep Venous Thrombosis: Safety of a Target INR 1.8. JAMA 2019 322(9):834-842. PMID 31479138; PMCID PMC6724181

Chan KK, Margro C, Shoushtari A, Rudin C, Rotemberg V, Rossi A, Lezcano C, Carrino J, Fernandez D, Postow MA, Apollo A, Lacouture ME, Bass AR. “Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature”. The Oncologist 2019 Oct Epub 2019 Oct 15.PMID: 32043775

Chan KK, Bass AR. Autoimmune Complications of Immunotherapy: Pathophysiology and Management. British Medical Journal Apr 6. PMID: 32253223

Ghosh N, Tiongson MD, Stewart.  C, Chan KK, Jivanelli B, Cappelli L, Bass AR. Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series. J Clin Rheumatol. 2020.PMID: 32345841

Chan KK, Tirpack A, Vitone G, Benson C, Nguyen J, Ghosh N, Jannat-Khah D, Bykerk V, Bass AR. Higher checkpoint inhibitor arthritis disease activity may be associated with cancer progression: Results from an observational registry in ACR Open Rheumatology 2020 ePub

Ghosh N, Tirpack A, Chan KK, Bass AR. Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey. J Immunother Cancer. 2020 Oct;8(2):e001550. PMID: 33067320; PMCID: PMC7569707.


Runci Wang, Karmela Kim Chan, Amy Cunningham-Bussel, Gregory Vitone, Aidan Tirpack, Caroline Benson, Gregory Keras, A. Helena Jonsson, Michael B. Brenner, Laura T. Donlin, Anne R. Bass*, Deepak A. Rao* Checkpoint Inhibitor-Associated Arthritis Synovial Fluid Mononuclear Cells: High-Dimensional Analyses Reveals a Unique, Proliferating CD38hi Cytotoxic CD8 T Cell Population Induced by Type 1 IFN. * co-senior authors. Plenary ACR Convergence, November 2020

Anne Bass, Bella Mehta, Peter Sculco, Yi Zhang, Huong Do, Linda Russell and Susan Goodman. The Risk of Venous Thromboembolism After Septic Total Knee Replacement (TKR) Revision Is Double the Risk After Aseptic TKR Revision: An Analysis of Administrative Discharge Data. Oral presentation ACR Convergence, November 2020

Nilasha Ghosh, Karmela Kim Chan, Bridget Jivanelli and Anne Bass. Over Half of Patients with Immune Checkpoint Inhibitor-related Myositis, Myasthenia Gravis and/or Myocarditis Have Autoantibodies: Results from a Systematic Literature Review. Poster ACR Convergence, November 2020

Research Interests

  • Are racial disparities in TKR revision risk explained by hospital or surgeon choice? (CJRC grant)
  • Biomarkers of checkpoint inhibitor-associated arthritis & autoimmunity (PI Karmela Chan)

Clinical Trials